AbSci
  • Our Technology
  • Partnerships
  • About Us
  • Careers
  • News / Updates
  • Contact
  • Facebook
  • Twitter
  • Linkedin
Select Page
AbSci hopes to make E. Coli great again through engineered expression system

AbSci hopes to make E. Coli great again through engineered expression system

Feb 7, 2018 | Article, News, Press

AbSci says its genetically engineered E. coli expression platform has produced yields exceeding 20 g/L for difficult to express products and threatens the dominance of mammalian systems …

AbSci Adds Protein Characterization Expert, Alan Herman, PhD to Scientific Advisory Board

AbSci Adds Protein Characterization Expert, Alan Herman, PhD to Scientific Advisory Board

Feb 5, 2018 | Announcement, Press

“There’s an electricity of discovery here like Genentech and Amgen,” said Dr. Herman. “AbSci’s ability to fold proteins is an innovative art form. This technology enables more efficient manufacturing, which will bring down the price of drugs.”

Recent Posts

  • Sanofi turns to high titer E. Coli platform in AbSci deal
  • AbSci Establishes New Collaboration with Sanofi  
  • SoluPro™ featured in Science Magazine
  • AbSci’s Founder and CEO, Sean McClain, named to Forbes 30 Under 30 list in Science 2019
  • AbSci Appoints Andrew J.S. Jones, D. Phil to Scientific Advisory Board

Archives

  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • July 2018
  • May 2018
  • February 2018
  • January 2018
  • December 2017
  • October 2017
  • August 2017
  • April 2017
  • January 2017
  • October 2016
  • August 2016
  • May 2016
  • April 2016
  • October 2015
SEE ARCHIVE

Categories

  • Announcement
  • Article
  • Award
  • Fundraising
  • News
  • Press

    Designed by Elegant Themes | Powered by WordPress